NCT00002560View on ClinicalTrials.gov

Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 1994

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

monoclonal antibody 3F8

BIOLOGICAL

sargramostim

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER